Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients

Citation
Jj. Lipuma et al., Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients, J CLIN MICR, 37(10), 1999, pp. 3167-3170
Citations number
21
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Microbiology
Journal title
JOURNAL OF CLINICAL MICROBIOLOGY
ISSN journal
00951137 → ACNP
Volume
37
Issue
10
Year of publication
1999
Pages
3167 - 3170
Database
ISI
SICI code
0095-1137(199910)37:10<3167:DORPAF>2.0.ZU;2-U
Abstract
PCR assays targeting rRNA genes were developed to identify species (genomov ars) within the Burkholderia cepacia complex. Each assay was tested with 17 7 bacterial isolates that also underwent taxonomic analysis by whole-cell p rotein profile. These isolates were from clinical and environmental sources and included 107 B. cepacia complex strains, 23 Burkholderia gladioli stra ins, 20 Ralstonia pickettii strains, 10 Pseudomonas aeruginosa strains, 8 S tenotrophomonas maltophilia strains, and 9 isolates belonging to nine other species, The sensitivity and specificity of the 16S rRNA-based assay for B urkholderia multivorans (genomovar II) were 100 and 99%, respectively; for Burkholderia vietnamiensis (genomovar V), sensitivity and specificity were 87 and 92%, respectively, An assay based on 16S and 23S rRNA gene analysis of B, cepacia ATCC 25416 (genomovar I) was useful in identifying genomovars I, III, and TV as a group (sensitivity, 100%, and specificity, 99%), Anoth er assay, designed to be specific at the genus level, identified all but on e of the Burkholderia and Ralstonia isolates tested (sensitivity, 99%, and specificity, 96%), The combined use of these assays offers a significant im provement over previously published PCR assays for B. cepacia.